Skip to main content
Top
Published in: BMC Psychiatry 1/2017

Open Access 01-12-2017 | Research article

Developing a decision tool to identify patients with personality disorders in need of highly specialized care

Authors: M. Goorden, E. M. C. Willemsen, C. A. M. Bouwmans-Frijters, J. J. V. Busschbach, M. J. Noomx, C. M. van der Feltz-Cornelis, C. A. Uyl-de Groot, L. Hakkaart-van Roijen

Published in: BMC Psychiatry | Issue 1/2017

Login to get access

Abstract

Background

Current guidelines recommend referral to highly specialized care for patients with severe personality disorders. However, criteria for allocation to highly specialized care are not clearly defined. The aim of the present study was to develop a decision tool that can support clinicians to identify patients with a personality disorder in need of highly specialized care.

Methods

Steps taken to develop a decision tool were a literature search, concept mapping, a meeting with experts and a validation study.

Results

The concept mapping method resulted in six criteria for the decision tool. The model used in concept mapping provided a good fit (stress value = 0.30) and reasonable reliability (ρ = 0.49). The bridging values were low, indicating homogeneity. The decision tool was subsequently validated by enrolling 368 patients from seven centers. A multilevel model with a Receiver Operating Characteristic Curve (ROC) was applied. In this way, an easily implementable decision tool with relatively high sensitivity (0.74) and specificity (0.69) was developed.

Conclusions

A decision tool to identify patients with personality disorders for highly specialized care was developed using advanced methods to combine the input of experts with currently available scientific knowledge. The tool appeared to be able to accurately identify this group of patients. Clinicians can use this decision tool to identify patients who are in need of highly specialized treatment.
Appendix
Available only for authorised users
Footnotes
1
M.G (First Author) and D.S. (acknowledgements)
 
2
GAF = Global Assessment of Functioning scale [25]. It is a scale that is used by clinicians for rating social, occupational and psychological functioning of an individual.
 
Literature
1.
go back to reference Lenzenweger MF. Epidemiology of personality disorders. Psychiatr Clin North Am. 2008;31(3):395–403. viCrossRefPubMed Lenzenweger MF. Epidemiology of personality disorders. Psychiatr Clin North Am. 2008;31(3):395–403. viCrossRefPubMed
2.
go back to reference Soeteman DI, Hakkaart-van Roijen L, Verheul R, Busschbach JJ. The economic burden of personality disorders in mental health care. J Clin Psychiatry. 2008;69(2):259–65.CrossRefPubMed Soeteman DI, Hakkaart-van Roijen L, Verheul R, Busschbach JJ. The economic burden of personality disorders in mental health care. J Clin Psychiatry. 2008;69(2):259–65.CrossRefPubMed
3.
go back to reference Skodol AE, Gunderson JG, McGlashan TH, Dyck IR, Stout RL, Bender DS, Grilo CM, Shea MT, Zanarini MC, Morey LC, Sanislow CA, Oldham JM. Functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorder. Am J Psychiatry. 2002;159(2):276–83.CrossRefPubMed Skodol AE, Gunderson JG, McGlashan TH, Dyck IR, Stout RL, Bender DS, Grilo CM, Shea MT, Zanarini MC, Morey LC, Sanislow CA, Oldham JM. Functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorder. Am J Psychiatry. 2002;159(2):276–83.CrossRefPubMed
4.
go back to reference Bender DS, Dolan RT, Skodol AE, Sanislow CA, Dyck IR, McGlashan TH, Shea MT, Zanarini MC, Oldham JM, Gunderson JG. Treatment utilization by patients with personality disorders. Am J Psychiatry. 2001;158(2):295–302.CrossRefPubMed Bender DS, Dolan RT, Skodol AE, Sanislow CA, Dyck IR, McGlashan TH, Shea MT, Zanarini MC, Oldham JM, Gunderson JG. Treatment utilization by patients with personality disorders. Am J Psychiatry. 2001;158(2):295–302.CrossRefPubMed
5.
go back to reference Moran P, Rendu A, Jenkins R, Tylee A, Mann A. The impact of personality disorder in UK primary care: a 1-year follow-up of attenders. Psychol Med. 2001;31(8):1447–54.CrossRefPubMed Moran P, Rendu A, Jenkins R, Tylee A, Mann A. The impact of personality disorder in UK primary care: a 1-year follow-up of attenders. Psychol Med. 2001;31(8):1447–54.CrossRefPubMed
6.
go back to reference Bateman A, Fonagy P. Health service utilization costs for borderline personality disorder patients treated with psychoanalytically oriented partial hospitalization versus general psychiatric care. Am J Psychiatry. 2003;160(1):169–71.CrossRefPubMed Bateman A, Fonagy P. Health service utilization costs for borderline personality disorder patients treated with psychoanalytically oriented partial hospitalization versus general psychiatric care. Am J Psychiatry. 2003;160(1):169–71.CrossRefPubMed
7.
go back to reference Tyrer P. The problem of severity in the classification of personality disorder. J Personal Disord. 2005;19(3):309–14.CrossRef Tyrer P. The problem of severity in the classification of personality disorder. J Personal Disord. 2005;19(3):309–14.CrossRef
8.
go back to reference Tyrer P, Reed GM, Crawford MJ. Classification, assessment, prevalence, and effect of personality disorder. Lancet. 2015;385(9969):717–26.CrossRefPubMed Tyrer P, Reed GM, Crawford MJ. Classification, assessment, prevalence, and effect of personality disorder. Lancet. 2015;385(9969):717–26.CrossRefPubMed
9.
go back to reference Soeteman DI, Timman R, Trijsburg RW, Verheul R, Busschbach JJ. Assessment of the burden of disease among inpatients in specialized units that provide psychotherapy. Psychiatr Serv. 2005;56(9):1153–5.CrossRefPubMed Soeteman DI, Timman R, Trijsburg RW, Verheul R, Busschbach JJ. Assessment of the burden of disease among inpatients in specialized units that provide psychotherapy. Psychiatr Serv. 2005;56(9):1153–5.CrossRefPubMed
10.
go back to reference Sobocki P, Ekman M, Agren H, Krakau I, Runeson B, Martensson B, Jonsson B. Health-related quality of life measured with EQ-5D in patients treated for depression in primary care. Value Health. 2007;10(2):153–60.CrossRefPubMed Sobocki P, Ekman M, Agren H, Krakau I, Runeson B, Martensson B, Jonsson B. Health-related quality of life measured with EQ-5D in patients treated for depression in primary care. Value Health. 2007;10(2):153–60.CrossRefPubMed
11.
go back to reference Verheul R. Clinical utility of dimensional models for personality pathology. J Personal Disord. 2005;19(3):283–302.CrossRef Verheul R. Clinical utility of dimensional models for personality pathology. J Personal Disord. 2005;19(3):283–302.CrossRef
12.
go back to reference Landelijke Stuurgroep Multidisciplinaire Richtlijnontwikkeling in de GGZ: Multidisciplinaire richtlijn persoonlijkheidsstoornissen. 2008, AF0806:1–208. Landelijke Stuurgroep Multidisciplinaire Richtlijnontwikkeling in de GGZ: Multidisciplinaire richtlijn persoonlijkheidsstoornissen. 2008, AF0806:1–208.
13.
14.
go back to reference Crawford MJ, Koldobsky N, Mulder R, Tyrer P. Classifying personality disorder according to severity. J Personal Disord. 2011;25(3):321–30.CrossRef Crawford MJ, Koldobsky N, Mulder R, Tyrer P. Classifying personality disorder according to severity. J Personal Disord. 2011;25(3):321–30.CrossRef
15.
go back to reference Kane M, Trochim W. Concept mapping for planning and evaluation. California: Sage publications, Inc; 2006. Kane M, Trochim W. Concept mapping for planning and evaluation. California: Sage publications, Inc; 2006.
16.
go back to reference Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.CrossRefPubMedPubMedCentral Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.CrossRefPubMedPubMedCentral
17.
go back to reference Concept Systems Incorporated. The concept system CS global software guide version 4.0. New York: Concept Systems Incorporated; 2011. Concept Systems Incorporated. The concept system CS global software guide version 4.0. New York: Concept Systems Incorporated; 2011.
18.
go back to reference Trochim W. An introduction to concept mapping for planning and evaluation. Eval Program Plann. 1989;12:1–16.CrossRef Trochim W. An introduction to concept mapping for planning and evaluation. Eval Program Plann. 1989;12:1–16.CrossRef
19.
go back to reference van Manen JG, Kamphuis JH, Goossensen A, Timman R, Busschbach JJ, Verheul R. In search of patient characteristics that may guide empirically based treatment selection for personality disorder patients-a concept map approach. J Personal Disord. 2012;26(4):481–97.CrossRef van Manen JG, Kamphuis JH, Goossensen A, Timman R, Busschbach JJ, Verheul R. In search of patient characteristics that may guide empirically based treatment selection for personality disorder patients-a concept map approach. J Personal Disord. 2012;26(4):481–97.CrossRef
20.
go back to reference Bedi RP. Concept mapping the client’s perspective on counseling alliance formation. J Couns Psychol. 2006;53(1):26–35.CrossRef Bedi RP. Concept mapping the client’s perspective on counseling alliance formation. J Couns Psychol. 2006;53(1):26–35.CrossRef
21.
go back to reference Stoffers JM, Vollm BA, Rucker G, Timmer A, Huband N, Lieb K. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 2012;(8). doi:10.1002/14651858. Stoffers JM, Vollm BA, Rucker G, Timmer A, Huband N, Lieb K. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 2012;(8). doi:10.​1002/​14651858.
22.
go back to reference Gunderson JG, Daversa MT, Grilo CM, McGlashan TH, Zanarini MC, Shea MT, Skodol AE, Yen S, Sanislow CA, Bender DS, Dyck IR, Morey LC, Stout RL. Predictors of 2-year outcome for patients with borderline personality disorder. Am J Psychiatry. 2006;163(5):822–6.CrossRefPubMed Gunderson JG, Daversa MT, Grilo CM, McGlashan TH, Zanarini MC, Shea MT, Skodol AE, Yen S, Sanislow CA, Bender DS, Dyck IR, Morey LC, Stout RL. Predictors of 2-year outcome for patients with borderline personality disorder. Am J Psychiatry. 2006;163(5):822–6.CrossRefPubMed
23.
go back to reference Barnicot K, Katsakou C, Marougka S, Priebe S. Treatment completion in psychotherapy for borderline personality disorder: a systematic review and meta-analysis. Acta Psychiatr Scand. 2011;123(5):327–38.CrossRefPubMed Barnicot K, Katsakou C, Marougka S, Priebe S. Treatment completion in psychotherapy for borderline personality disorder: a systematic review and meta-analysis. Acta Psychiatr Scand. 2011;123(5):327–38.CrossRefPubMed
24.
go back to reference Newton-Howes G, Clark LA, Chanen A. Personality disorder across the life course. Lancet. 2015;385(9969):727–34.CrossRefPubMed Newton-Howes G, Clark LA, Chanen A. Personality disorder across the life course. Lancet. 2015;385(9969):727–34.CrossRefPubMed
25.
go back to reference Jones SH, Thornicroft G, Coffey M, Dunn G. A brief mental health outcome scale-reliability and validity of the Global Assessment of Functioning (GAF). Br J Psychiatry. 1995;166(5):654–9.CrossRefPubMed Jones SH, Thornicroft G, Coffey M, Dunn G. A brief mental health outcome scale-reliability and validity of the Global Assessment of Functioning (GAF). Br J Psychiatry. 1995;166(5):654–9.CrossRefPubMed
26.
go back to reference Barnow S, Arens EA, Sieswerda S, Dinu-Biringer R, Spitzer C, Lang S. Borderline personality disorder and psychosis: a review. Curr Psychiatry Rep. 2010;12(3):186–95.CrossRefPubMed Barnow S, Arens EA, Sieswerda S, Dinu-Biringer R, Spitzer C, Lang S. Borderline personality disorder and psychosis: a review. Curr Psychiatry Rep. 2010;12(3):186–95.CrossRefPubMed
27.
go back to reference Chiesa M, Sharp R, Fonagy P. Clinical associations of deliberate self-injury and its impact on the outcome of community-based and long-term inpatient treatment for personality disorder. Psychother Psychosom. 2011;80(2):100–9.CrossRefPubMed Chiesa M, Sharp R, Fonagy P. Clinical associations of deliberate self-injury and its impact on the outcome of community-based and long-term inpatient treatment for personality disorder. Psychother Psychosom. 2011;80(2):100–9.CrossRefPubMed
28.
go back to reference Goodman G, Hull JW, Clarkin JF, Yeomans FE. Comorbid mood disorders as modifiers of treatment response among inpatients with borderline personality disorder. J Nerv Ment Dis. 1998;186(10):616–22.CrossRefPubMed Goodman G, Hull JW, Clarkin JF, Yeomans FE. Comorbid mood disorders as modifiers of treatment response among inpatients with borderline personality disorder. J Nerv Ment Dis. 1998;186(10):616–22.CrossRefPubMed
29.
go back to reference McMurran M, Huband N, Overton E. Non-completion of personality disorder treatments: a systematic review of correlates, consequences, and interventions. Clin Psychol Rev. 2010;30(3):277–87.CrossRefPubMed McMurran M, Huband N, Overton E. Non-completion of personality disorder treatments: a systematic review of correlates, consequences, and interventions. Clin Psychol Rev. 2010;30(3):277–87.CrossRefPubMed
30.
go back to reference Ryle A, Golynkina K. Effectiveness of time-limited cognitive analytic therapy of borderline personality disorder: factors associated with outcome. Br J Med Psychol. 2000;73(Pt 2):197–210.CrossRefPubMed Ryle A, Golynkina K. Effectiveness of time-limited cognitive analytic therapy of borderline personality disorder: factors associated with outcome. Br J Med Psychol. 2000;73(Pt 2):197–210.CrossRefPubMed
31.
go back to reference Skodol AE, Siever LJ, Livesley WJ, Gunderson JG, Pfohl B, Widiger TA. The borderline diagnosis II: biology, genetics, and clinical course. Biol Psychiatry. 2002;51(12):951–63.CrossRefPubMed Skodol AE, Siever LJ, Livesley WJ, Gunderson JG, Pfohl B, Widiger TA. The borderline diagnosis II: biology, genetics, and clinical course. Biol Psychiatry. 2002;51(12):951–63.CrossRefPubMed
32.
go back to reference Thormahlen B, Weinryb RM, Norén K, Vinnars B, Bågedahl-Strindlund M. Patient factors predicting dropout from supportive-expressive psychotherapy for patients with personality disorders. Psychother Res. 2003;13(4):493–509. Thormahlen B, Weinryb RM, Norén K, Vinnars B, Bågedahl-Strindlund M. Patient factors predicting dropout from supportive-expressive psychotherapy for patients with personality disorders. Psychother Res. 2003;13(4):493–509.
33.
go back to reference Yen S, Shea MT, Battle CL, Johnson DM, Zlotnick C, Dolan-Sewell R, Skodol AE, Grilo CM, Gunderson JG, Sanislow CA, Zanarini MC, Bender DS, Rettew JB, McGlashan TH. Traumatic exposure and posttraumatic stress disorder in borderline, schizotypal, avoidant, and obsessive-compulsive personality disorders: findings from the collaborative longitudinal personality disorders study. J Nerv Ment Dis. 2002;190(8):510–8.CrossRefPubMed Yen S, Shea MT, Battle CL, Johnson DM, Zlotnick C, Dolan-Sewell R, Skodol AE, Grilo CM, Gunderson JG, Sanislow CA, Zanarini MC, Bender DS, Rettew JB, McGlashan TH. Traumatic exposure and posttraumatic stress disorder in borderline, schizotypal, avoidant, and obsessive-compulsive personality disorders: findings from the collaborative longitudinal personality disorders study. J Nerv Ment Dis. 2002;190(8):510–8.CrossRefPubMed
34.
go back to reference Yoshida K, Tonai E, Nagai H, Matsushima K, Matsushita M, Tsukada J, Kiyohara Y, Nishimura R. Long-term follow-up study of borderline patients in Japan: a preliminary study. Compr Psychiatry. 2006;47(5):426–32.CrossRefPubMed Yoshida K, Tonai E, Nagai H, Matsushima K, Matsushita M, Tsukada J, Kiyohara Y, Nishimura R. Long-term follow-up study of borderline patients in Japan: a preliminary study. Compr Psychiatry. 2006;47(5):426–32.CrossRefPubMed
Metadata
Title
Developing a decision tool to identify patients with personality disorders in need of highly specialized care
Authors
M. Goorden
E. M. C. Willemsen
C. A. M. Bouwmans-Frijters
J. J. V. Busschbach
M. J. Noomx
C. M. van der Feltz-Cornelis
C. A. Uyl-de Groot
L. Hakkaart-van Roijen
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2017
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-017-1460-6

Other articles of this Issue 1/2017

BMC Psychiatry 1/2017 Go to the issue